Trial intelligence / Profile preview

Effect of Itraconazole on Basmisanil Pharmacokinetics in Healthy Subjects

NCT02470832Phase 1Completed

Sponsor
Roche
Start
May 2015
Primary completion
Jul 2015
Modality
Small Molecules
Countries
1
01

Overview

Phase 1, open-label, single-arm trial of basmisanil in Down syndrome, sponsored by Roche. Primary endpoints: Area under the plasma concentration-time curve from 0-t, Maximum observed plasma concentration and 1 more. Started May 2015; status: completed.

02

Drugs

basmisanil
03

Conditions

Down syndrome

Beyond the preview

Go deeper on NCT02470832.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02470832.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call